Total trials
287
Active
85
Phase 3
0
Total enrollment
22,846
Pipeline matrix
Showing 14 of 14 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Postoperative analgesia management | — | — | — | — | — | 6 | |
| Erector spinae plane block | — | — | — | — | — | 2 | |
| Urine-Derived Exosomes | — | — | — | — | — | 1 | |
| Daily Phosphodiesterase type 5 (PDE5) Inhibitor | — | — | — | — | — | 1 | |
| local infiltration | — | — | — | — | — | 1 | |
| PENG | — | — | — | — | — | 1 | |
| FİB | — | — | — | — | — | 1 | |
| serotonin reuptake inhibitor | — | — | — | — | — | 1 | |
| oral isotretinoin | — | — | — | — | — | 1 | |
| Standard Postoperative Analgesia | — | — | — | — | — | 1 | |
| Sugammadex | — | — | — | — | — | 1 | |
| SPS block | — | — | — | — | — | 1 | |
| Surgical Intercostal Blockade. | — | — | — | — | — | 1 | |
| Serratus posterior superior intercostal plane block | — | — | — | — | — | 1 |
Next readouts
- 2025-12-31
- 2026-05-30
- 2026-06-01
- 2026-06-01
- 2026-09-20
- 2026-10-01
- 2026-11-20
- 2027-01-01
Top conditions
- Cerebral Palsy (CP)7
- Lumbar Disc Herniation7
- Lung Diseases6
- Stroke5
- Quality of Life5
- Breast Cancer5
- Postoperative Pain5
- Rotator Cuff Syndrome4
Frequently asked questions about Medipol University
- How many clinical trials does Medipol University have on ClinicalTrials.gov?
- Medipol University is listed as the lead sponsor on 287 clinical trials in ClinicalTrials.gov, 85 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medipol University's trials are in Phase 3?
- 0 of Medipol University's trials are in Phase 3, spread across 14 active drug programs.
- What therapeutic areas does Medipol University focus on?
- Medipol University's most-studied conditions on ClinicalTrials.gov are Cerebral Palsy (CP), Lumbar Disc Herniation, Lung Diseases, Stroke, Quality of Life.
- When are Medipol University's next clinical trial readouts?
- Medipol University has 8 upcoming primary-completion readouts tracked here; the soonest is “Effect of Systemic Retinoic Acid Use on Micro Ribonucleic Acid (mRNA) Expression”, expected around 2025-12-31.